Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.045 CAD | -25.00% |
|
0.00% | -62.50% |
Jun. 20 | Sirona Biochem Corp. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024 | CI |
May. 07 | Sirona Biochem Engages Stonegate Healthcare Partners | CI |
Sales 2022 | 672K 494K | Sales 2023 | 34.78K 25.56K | Capitalization | 21.44M 15.76M |
---|---|---|---|---|---|
Net income 2022 | -3M -2.2M | Net income 2023 | -2M -1.47M | EV / Sales 2022 | 48.8 x |
Net Debt 2022 | 48.04K 35.3K | Net Debt 2023 | 1.61M 1.18M | EV / Sales 2023 | 663 x |
P/E ratio 2022 |
-8.81
x | P/E ratio 2023 |
-8.43
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 89.43% |
1 day | +20.00% | ||
1 week | +20.00% | ||
Current month | +33.33% | ||
1 month | +9.09% | ||
3 months | -14.29% | ||
6 months | -50.00% | ||
Current year | -50.00% |
![Extreme 0.04](/images/extremecours_fleche.png)
![Extreme 0.04](/images/extremecours_fleche.png)
![Extreme 0.04](/images/extremecours_fleche.png)
![Extreme 0.04](/images/extremecours_fleche.png)
![Extreme 0.04](/images/extremecours_fleche.png)
![Extreme 0.04](/images/extremecours_fleche.png)
![Extreme 0.04](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Howard Verrico
CEO | Chief Executive Officer | - | 06-10-18 |
Director of Finance/CFO | - | 09-04-28 | |
Chief Tech/Sci/R&D Officer | - | 11-03-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Howard Verrico
CEO | Chief Executive Officer | - | 06-10-18 |
Alex Marazzi
BRD | Director/Board Member | - | 06-10-18 |
Director of Finance/CFO | - | 09-04-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-05 | 0.045 | -25.00% | 139 012 |
24-07-04 | 0.06 | +20.00% | 73,010 |
24-07-03 | 0.05 | +25.00% | 30,000 |
24-07-02 | 0.04 | -11.11% | 53,900 |
Delayed Quote Toronto S.E., July 04, 2024 at 03:59 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-50.00% | 11.32M | |
+16.59% | 44.44B | |
+41.02% | 40.03B | |
-10.62% | 37.68B | |
+29.92% | 31.46B | |
-9.23% | 27.29B | |
+12.34% | 26.29B | |
+41.53% | 13.8B | |
+31.49% | 12.46B | |
-7.40% | 11.26B |
- Stock Market
- Equities
- SBM Stock